Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

    Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes1,2 and molecular mechanisms that are often specific to cell type3,4. Here, to characterize the genetic c...

    Ken Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam, Henry J. Taylor in Nature (2024)

  2. Article

    Open Access

    Prevalence and prognosis of genetically proven familial hypercholesterolemia in subjects with coronary artery disease and reduced ejection fraction

    Few studies have genetically screened variants related to familial hypercholesterolemia (FH) and investigated their survival impact in patients with coronary artery disease (CAD) and reduced left ventricular e...

    Wen-Jane Lee, Han-Ni Chuang, Tzu-Hung Hsiao, Wen-Lieng Lee in Scientific Reports (2023)

  3. Article

    Open Access

    Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

    Studies that have reported lower risk for cardiovascular outcomes in users of Sodium–Glucose Cotransporter-2 Inhibitors (SGLT-2i) are limited by residual cofounding and lack of information on prior cardiovascu...

    Dorte Vistisen, Bendix Carstensen, Patorno Elisabetta in Cardiovascular Diabetology (2023)

  4. Article

    Open Access

    Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

    Most transcriptome-wide association studies (TWASs) so far focus on European ancestry and lack diversity. To overcome this limitation, we aggregated genome-wide association study (GWAS) summary statistics, who...

    Fang Chen, **ngyan Wang, Seon-Kyeong Jang, Bryan C. Quach in Nature Genetics (2023)

  5. Article

    Open Access

    A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes

    The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler w...

    Hertzel C. Gerstein, Chinthanie Ramasundarahettige in Cardiovascular Diabetology (2022)

  6. Article

    Open Access

    Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries

    Family history (FamH) of type 2 diabetes might indicate shared genotypes, environments, and/or behaviors. We hypothesize that FamH interacts with unhealthy behaviors to increase the risk of early onset of diab...

    Johnny T. K. Cheung, Eric Lau, Cyrus C. T. Tsui, Edmond L. N. Siu in BMC Medicine (2022)

  7. No Access

    Article

    Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation

    We assembled an ancestrally diverse collection of genome-wide association studies (GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non-European descent) through the...

    Anubha Mahajan, Cassandra N. Spracklen, Weihua Zhang, Maggie C. Y. Ng in Nature Genetics (2022)

  8. Article

    Open Access

    Rare coding variants in RCN3 are associated with blood pressure

    While large genome-wide association studies have identified nearly one thousand loci associated with variation in blood pressure, rare variant identification is still a challenge. In family-based cohorts, geno...

    Karen Y. He, Tanika N. Kelly, Heming Wang, **g**g Liang, Luke Zhu in BMC Genomics (2022)

  9. No Access

    Article

    Subjects with coronary artery disease and reduced ejection fraction have longer (GT)n repeats in the heme-oxygenase 1 gene promoter

    Heme oxygenase (HO)-1 is a rate-limiting enzyme for degrading heme into carbon monoxide. Longer (GT)n repeat of the HO-1 gene (HMOX1) promoter has a lower transcription rate. Subjects with longer GT repeats in th...

    Kae-Woei Liang, Wen-Jane Lee, Wen-Lieng Lee, Jen-Pey Wu, I-Te Lee in Heart and Vessels (2021)

  10. Article

    Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals

    A Correction to this paper has been published: https://doi.org/10.1038/s41588-021-00832-z.

    Praveen Surendran, Elena V. Feofanova, Najim Lahrouchi, Ioanna Ntalla in Nature Genetics (2021)

  11. Article

    Open Access

    Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

    Pharmaceutical drugs targeting dyslipidemia and cardiovascular disease (CVD) may increase the risk of fatty liver disease and other metabolic disorders. To identify potential novel CVD drug targets without the...

    Jonas B. Nielsen, Oren Rom, Ida Surakka, Sarah E. Graham, Wei Zhou in Nature Communications (2020)

  12. No Access

    Article

    Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals

    Genetic studies of blood pressure (BP) to date have mainly analyzed common variants (minor allele frequency > 0.05). In a meta-analysis of up to ~1.3 million participants, we discovered 106 new BP-associated g...

    Praveen Surendran, Elena V. Feofanova, Najim Lahrouchi, Ioanna Ntalla in Nature Genetics (2020)

  13. Article

    Open Access

    Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

    The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) double blind randomized trial demonstrated that weekly subcutaneous dulaglutide 1.5 mg, a glucagon like peptide-1 receptor agon...

    Gilles R. Dagenais, Lars Rydén, Lawrence A. Leiter in Cardiovascular Diabetology (2020)

  14. Article

    Open Access

    Impact of Liver Cirrhosis on Incidence of Dialysis Among Patients with Type 2 Diabetes

    Renal injury is a common complication of liver cirrhosis and type 2 diabetes mellitus (T2DM). The aim of this study was to analyze the association between cirrhosis and dialysis in patients with T2DM.

    Yi-**g Sheen, Pei-Tseng Kung, Wayne H.-H. Sheu, Wei-Yin Kuo in Diabetes Therapy (2020)

  15. No Access

    Article

    Identification of type 2 diabetes loci in 433,540 East Asian individuals

    Meta-analyses of genome-wide association studies (GWAS) have identified more than 240 loci that are associated with type 2 diabetes (T2D)1,2; however, most of these loci have been identified in analyses of indivi...

    Cassandra N. Spracklen, Momoko Horikoshi, Young ** Kim, Kuang Lin, Fiona Bragg in Nature (2020)

  16. Article

    Open Access

    Associations of autozygosity with a broad range of human phenotypes

    In many species, the offspring of related parents suffer reduced reproductive success, a phenomenon known as inbreeding depression. In humans, the importance of this effect has remained unclear, partly because...

    David W Clark, Yukinori Okada, Kristjan H S Moore, Dan Mason in Nature Communications (2019)

  17. Article

    Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Valérie Turcot, Yingchang Lu, Heather M. Highland, Claudia Schurmann in Nature Genetics (2019)

  18. No Access

    Article

    Impact of Anthracyclines on Diabetes Mellitus Development in B-Cell Lymphoma Patients: A Nationwide Population-based Study

    Although anthracyclines are effective chemotherapeutic agents for treating B-cell lymphoma, adverse effects, such as bone marrow suppression and cardiotoxicity, limit their clinical application. We assessed wh...

    Chieh-Lin Jerry Teng, Kuang-Hsi Chang, I-Ju Tsai in Clinical Drug Investigation (2018)

  19. Article

    Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    In the version of this article originally published, one of the two authors with the name Wei Zhao was omitted from the author list and the affiliations for both authors were assigned to the single Wei Zhao in...

    Valérie Turcot, Yingchang Lu, Heather M. Highland, Claudia Schurmann in Nature Genetics (2018)

  20. Article

    Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    In the published version of this paper, the name of author Emanuele Di Angelantonio was misspelled. This error has now been corrected in the HTML and PDF versions of the article.

    Valérie Turcot, Yingchang Lu, Heather M. Highland, Claudia Schurmann in Nature Genetics (2018)

previous disabled Page of 3